Food-Derived Bioactive Peptides: A Promising Substitute to Chemosynthetic Drugs Against the Dysregulated Renin-Angiotensin System in COVID-19 Patients

References

• Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., Chen, H.D., Chen, J., Luo, Y., Guo, H., Jiang, R.D., Liu, M.Q., Chen, Y., Shen, X.R., Wang, X., Zheng, X.S., Zhao, K., Chen, Q.J., Deng, F., Liu, L.L., Yan, B., Zhan, F.X., Wang, Y.Y., Xiao, G.F. and Shi, Z.L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579(7798): 270-273.
   PubMed Web of Science ®Google Scholar
• WHO. (2021b, 09-06-2021). WHO Coronavirus (COVID-19) Dashboard. Retrieved from https://covid19.who.int/
   Google Scholar
• Begum, D. and Nagaraju, G.P. (2020). Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients. Cytokine Growth Factor Reviews. 53: 43-52.
   PubMed Web of Science ®Google Scholar
• Patel, A.B. and Verma, A. (2020). COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? Jama. 323(18): 1769-1770.
   PubMed Web of Science ®Google Scholar
• Fang, L., Karakiulakis, G. and Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet. Respiratory Medicine. 8(4): e21.
   PubMed Web of Science ®Google Scholar
• Đambić, V., Pojatić, Đ., Stažić, A. and Kibel, A. (2020). Significance of the Renin-Angiotensin System in Clinical Conditions. In Selected Chapters from the Renin-Angiotensin System. IntechOpen. 39 pp.
   Google Scholar
• Wu, Y. (2020). Compensation of ACE2 function for possible clinical management of 2019-nCoV-induced acute lung injury. Virologica Sinica. 35(3): 256-258.
   PubMed Web of Science ®Google Scholar
• Meng, J., Xiao, G., Zhang, J., He, X., Ou, M., Bi, J., Yang, R., Di, W., Wang, Z., Li, Z., Gao, H., Liu, L. and Zhang, G. (2020). Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerging Microbes and Infections. 9(1): 757-760.
   PubMed Web of Science ®Google Scholar
• McKinney, C.A., Fattah, C., Loughrey, C.M., Milligan, G. and Nicklin, S.A. (2014). Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling. Clinical Science. 126(12): 815-827.
   PubMed Web of Science ®Google Scholar
• e Silva, A.C.S. and Teixeira, M.M. (2016). ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacological Research. 107: 154-162.
   PubMed Web of Science ®Google Scholar
• Rahman, M.H., Zahan, M., Hasib, T., Ahmed, K., Khanam, M., Omit, M., Moni, A. and Uddin, M.J. (2020). Current knowledge on mechanisms involved in SARS-CoV-2 infection and kidney diseases. Journal of Advanced Biotechnology and Experimental Therapeutics. 3(4): 30-35.
   Google Scholar
• Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J.J., Pfeffer, M.A. and Solomon, S.D. (2020). Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. New England Journal of Medicine. 382(17): 1653-1659.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., Zhang, Z., Wang, L., Peng, L., Chen, L., Qin, Y., Zhao, D., Tan, S., Yin, L., Xu, J., Zhou, C., Jiang, C. and Liu, L. (2020). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China Life Sciences. 63(3): 364-374.
   PubMed Web of Science ®Google Scholar
• Devaux, C.A., Rolain, J.-M. and Raoult, D. (2020). ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. Journal of Microbiology, Immunology, and Infection. 53(3): 425-435.
   Web of Science ®Google Scholar
• Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., Sampaziotis, F., Worlock, K.B., Yoshida, M., Barnes, J.L. and HCA Lung Biological Network (2020). SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine. 26(5): 681-687.
   PubMed Web of Science ®Google Scholar
• Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.-L., Abiona, O., Graham, B.S. and McLellan, J.S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 367(6483): 1260-1263.
   PubMed Web of Science ®Google Scholar
• Wouters, O.J., Shadlen, K.C., Salcher-Konrad, M., Pollard, A.J., Larson, H.J., Teerawattananon, Y. and Jit, M. (2021). Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. The Lancet. 397(10278): 1023-1034.
   PubMed Web of Science ®Google Scholar
• WHO. (2020a). Update on COVID-19 vaccine development [Press release]. Retrieved from https://www.who.int/docs/default-source/coronaviruse/risk-comms-updates/update45-vaccines-developement.pdf?sfvrsn=13098bfc_5
   Google Scholar
• Gurwitz, D. (2020). Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Development Research. 81(5): 537-540.
   PubMed Web of Science ®Google Scholar
• Casarini, D.E., Aragão, D.S., Arita, D.Y., Ronchi, F.A., Marcondes, F.K., Bertoncello, N.S.C., Rosa, R.M. and Cunha, T.S. (2012). Up-Regulation of Renin-Angiotensin System in Diabetes and Hypertension: Implications on the Development of Diabetic Nephropathy. In Diabetic nephropathy: INTECH Open Access Publisher. doi: https://doi.org/10.5772/36852.
   Google Scholar
• Rossi, G.P., Sanga, V. and Barton, M. (2020). Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife. 9: e57278.
   PubMed Web of Science ®Google Scholar
• Sommerstein, R. and Gräni, C. (2020). Preventing a COVID-19 pandemic: ACE inhibitors as a potential risk factor for fatal COVID-19. BMJ. 368: m810.
   PubMed Web of Science ®Google Scholar
• Yang, Z., Liu, J., Zhou, Y., Zhao, X., Zhao, Q. and Liu, J. (2020). The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. Journal of Infection. 81(1): e13-e20.
   PubMed Web of Science ®Google Scholar
• NIH. (2020). Corticosteroids (Including Dexamethasone)-Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Retrieved from https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/corticosteroids/
   Google Scholar
• Lin, S.R., Lin, S.Y., Chen, C.C., Fu, Y.S. and Weng, C.F. (2019). Exploring a New Natural Treating Agent for Primary Hypertension: Recent Findings and Forthcoming Perspectives. Journal of Clinical Medicine. 8(11): 2003.
   Web of Science ®Google Scholar
• Hossain, K.S., Hossain, M.G., Moni, A., Rahman, M.M., Rahman, U.H., Alam, M., Kundu, S., Rahman, M.M., Hannan, M.A. and Uddin, M.J. (2020). Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises. Heliyon. 6(12): e05798.
   PubMed Web of Science ®Google Scholar
• Islam, M.N., Hossain, K.S., Sarker, P.P., Ferdous, J., Hannan, M.A., Rahman, M.M., Chu, D.T. and Uddin, M.J. (2021). Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure. Phytother. Res. 35(3): 1329-1344.
   PubMed Web of Science ®Google Scholar
• Xian, Y., Zhang, J., Bian, Z., Zhou, H., Zhang, Z., Lin, Z. and Xu, H. (2020). Bioactive natural compounds against human coronaviruses: a review and perspective. Acta Pharmaceutica Sinica. B. 10(7): 1163-1174.
   PubMed Web of Science ®Google Scholar
• Möller, N.P., Scholz-Ahrens, K.E., Roos, N. and Schrezenmeir, J. (2008). Bioactive peptides and proteins from foods: indication for health effects. European Journal of Nutrition. 47(4): 171-182.
   PubMed Web of Science ®Google Scholar
• Sánchez, A. and Vázquez, A. (2017). Bioactive peptides: A review. Food Quality Safety. 1(1): 29-46.
   Web of Science ®Google Scholar
• Daskaya-Dikmen, C., Yucetepe, A., Karbancioglu-Guler, F., Daskaya, H. and Ozcelik, B. (2017). Angiotensin-I-converting enzyme (ACE)-inhibitory peptides from plants. Nutrients. 9(4): 316.
   Web of Science ®Google Scholar
• Hernández-Ledesma, B., del Mar Contreras, M. and Recio, I. (2011). Antihypertensive peptides: production, bioavailability and incorporation into foods. Advances in colloid interface science. 165(1): 23-35.
   PubMed Web of Science ®Google Scholar
• Iwaniak, A., Minkiewicz, P. and Darewicz, M. (2014). Food-originating ACE inhibitors, including antihypertensive peptides, as preventive food components in blood pressure reduction. Comprehensive Reviews in Food Science and Food Safety. 13(2): 114-134.
   PubMed Web of Science ®Google Scholar
• Çakır, B., Okuyan, B., Şener, G. and Tunali-Akbay, T. (2021). Investigation of betalactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): in silico analysis. European Journal of Pharmacology. 891: 173781.
   PubMed Web of Science ®Google Scholar
• Shi, A.M., Guo, R., Wang, Q. and Zhou, J.R. (2021). Screening and Molecular Modeling Evaluation of Food Peptides to Inhibit Key Targets of COVID-19 Virus. Biomolecules. 11(2): 330.
   PubMed Web of Science ®Google Scholar
• Maiti, B.K. (2020). Potential role of peptide-based antiviral therapy against SARS-CoV-2 infection. ACS Pharmacology and Translational Science. 3(4): 783-785.
   PubMedGoogle Scholar
• Riyadi, P.H., Tanod, W.A., Wahyudi, D., Susanto, E., Fahmi, A. and Aisiah, S. (2020). Potential of tilapia (Oreochromis niloticus) viscera bioactive peptides as antiviral for SARS-CoV-2 (COVID 19). Paper presented at the IOP Conference Series: Earth and Environmental Science. 584: 012004.
   Google Scholar
• Padhi, S., Sanjukta, S., Chourasia, R., Labala, R.K., Singh, S.P. and Rai, A.K. (2021). A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study. Frontiers in Molecular Biosciences. 8: 198.
   Web of Science ®Google Scholar
• Wong, F.C., Ong, J.H., Kumar, D.T. and Chai, T.T. (2021). In Silico Identification of Multitarget Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins. International Journal of Peptide Research and Therapeutics. 1-11.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, R., Gupta, A.M., Mitra, S., Mandal, S. and Biswas, S.R.J.V. (2021). A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2. Virology. 552: 107-111.
   PubMed Web of Science ®Google Scholar
• Jahandideh, F., Chakrabarti, S., Majumder, K., Li, Q., Panahi, S., Morton, J.S., Davidge, S.T. and Wu, J. (2016). Egg white protein hydrolysate reduces blood pressure, improves vascular relaxation and modifies aortic angiotensin II receptors expression in spontaneously hypertensive rats. Journal of Functional Foods. 27: 667-673.
   Web of Science ®Google Scholar
• Lavigne, C., Marette, A. and Jacques, H. (2000). Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. American Journal of Physiology-Endocrinology Metabolism. 278(3): E491-E500.
   PubMed Web of Science ®Google Scholar
• Majumder, K., Chakrabarti, S., Morton, J.S., Panahi, S., Kaufman, S., Davidge, S.T. and Wu, J. (2015). Egg-derived ACE-inhibitory peptides IQW and LKP reduce blood pressure in spontaneously hypertensive rats. Journal of Functional Foods. 13: 50-60.
   Web of Science ®Google Scholar
• Majumder, K., Chakrabarti, S., Morton, J.S., Panahi, S., Kaufman, S., Davidge, S.T. and Wu, J. (2013). Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PloS One. 8(11): e82829.
   PubMed Web of Science ®Google Scholar
• Mojica, L., De Mejia, E.G., Menjivar, M. and Granados-Silvestre, M.Á. (2016). Antidiabetic Effect of Black Bean Peptides through Reduction of Glucose Absorption and Modulation of SGLT1, GLUT2 and DPP-IV in in vitro and in vivo Models. The FASEB Journal, 30(1_ supplement): 125.126-125.126.
   Web of Science ®Google Scholar
• Guan, W.J., Liang, W.H., Zhao, Y., Liang, H.R., Chen, Z.S., Li, Y.M., Liu, X.Q., Chen, R.C., Tang, C.L., Wang, T., Ou, C.Q., Li, L., Chen, P.Y., Sang, L., Wang, W., Li, J.F., Li, C.C., Ou, L.M., Cheng, B., Xiong, S., Ni, Z.Y., Xiang, J., Hu, Y., Liu, L., Shan, H., Lei, C.L., Peng, Y.X., Wei, L., Liu, Y., Hu, Y.H., Peng, P., Wang, J.M., Liu, J.Y., Chen, Z., Li, G., Zheng, Z.J., Qiu, S.Q., Luo, J., Ye, C.J., Zhu, S.Y., Cheng, L.L., Ye, F., Li, S.Y., Zheng, J.P., Zhang, N.F., Zhong, N.S. and He, J.X. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur. Respir. J. 55(5): 2000547.
   PubMed Web of Science ®Google Scholar
• Liu, H., Chen, S., Liu, M., Nie, H. and Lu, H. (2020). Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis. Aging Disease. 11(3): 668.
   PubMed Web of Science ®Google Scholar
• Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., Liu, L., Shan, H., Lei, C.L., Hui, D.S.C., Du, B., Li, L.J., Zeng, G., Yuen, K.Y., Chen, R.C., Tang, C.L., Wang, T., Chen, P.Y., Xiang, J., Li, S.Y., Wang, J.L., Liang, Z.J., Peng, Y.X., Wei, L., Liu, Y., Hu, Y.H., Peng, P., Wang, J.M., Liu, J.Y., Chen, Z., Li, G., Zheng, Z.J., Qiu, S.Q., Luo, J., Ye, C.J., Zhu, S.Y. and Zhong, N.S. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 382(18): 1708-1720.
   PubMed Web of Science ®Google Scholar
• Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S. and Hu, D. (2020). Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab. Res. Rev. 31: e3319.
   Google Scholar
• Kreutz, R., Algharably, E.A.E.-H., Azizi, M., Dobrowolski, P., Guzik, T., Januszewicz, A., Persu, A., Prejbisz, A., Riemer, T.G., Wang, J.G. and Burnier, M. (2020). Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19European Society of Hypertension COVID-19 Task Force Review of Evidence. Cardiovascular Research. 116(10): 1688-1699
   PubMed Web of Science ®Google Scholar
• Karalliedde, J. and Viberti, G. (2006). Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes. Journal of Human Hypertension. 20(4): 239-253.
   PubMed Web of Science ®Google Scholar
• Lim, H.S., MacFadyen, R.J. and Lip, G.Y. (2004). Diabetes mellitus, the renin-angiotensinaldosterone system, and the heart. Archives of Internal Medicine. 164(16): 1737-1748.
   PubMed Web of Science ®Google Scholar
• Gupta, R., Ghosh, A., Singh, A.K. and Misra, A. (2020). Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes & Metabolic Syndrome. 14(3): 211.
   PubMed Web of Science ®Google Scholar
• Imai, Y., Kuba, K. and Penninger, J.M. (2007). Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cellular and Molecular Life Sciences. 64(15): 2006-2012.
   PubMed Web of Science ®Google Scholar
• Chappel, M. and Ferrario, C. (2006). ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney International. 70(1): 8-10.
   PubMed Web of Science ®Google Scholar
• Santos, R., Ferreira, A.J., Verano-Braga, T. and Bader, M. (2013). Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. Journal of Endocrinology. 216(2): R1-R17.
   PubMed Web of Science ®Google Scholar
• Cha, S.A., Park, B.M. and Kim, S.H. (2018). Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor. The Korean Journal of Physiology & Pharmacology. 22(4): 447.
   PubMed Web of Science ®Google Scholar
• Zhou, M.S., Schulman, I.H. and Zeng, Q. (2012). Link between the renin-angiotensin system and insulin resistance: Implications for cardiovascular disease. Vascular Medicine. 17(5): 330-341.
   PubMed Web of Science ®Google Scholar
• Fyhrquist, F. and Saijonmaa, O. (2008). Renin-angiotensin system revisited. Journal of Internal Medicine. 264(3): 224-236.
   PubMed Web of Science ®Google Scholar
• Arendse, L.B., Danser, A.J., Poglitsch, M., Touyz, R.M., Burnett, J.C., Llorens-Cortes, C., Ehlers, M.R. and Sturrock, E.D. (2019). Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacological Reviews. 71(4): 539-570.
   PubMed Web of Science ®Google Scholar
• Li, S.R., Tang, Z.J., Li, Z.H. and Liu, X. (2020). Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV. European Journal of Clinical Microbiology & Infectious Diseases. 39(6): 1021.
   PubMed Web of Science ®Google Scholar
• Yang, C.-W., Lu, L.-C., Chang, C.-C., Cho, C.-C., Hsieh, W.-Y., Tsai, C.-H., Lin, Y.-C. and Lin, C.-S. (2017). Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis session. Renal Failure. 39(1): 719-728.
   PubMed Web of Science ®Google Scholar
• Tolouian, R., Vahed, S.Z., Ghiyasvand, S., Tolouian, A. and Ardalan, M. (2020). COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment. Journal of Renal Injury Prevention. 9(2): e19.
   Google Scholar
• Delbridge, L.M., Bienvenu, L.A. and Mellor, K.M. (2016). Angiotensin-(1-9): New Promise for Post-Infarct Functional Therapy. Journal of the American College of Cardiology. 68(24): 2667-2669.
   PubMed Web of Science ®Google Scholar
• Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K., Greenough, T.C., Choe, H., Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426(6965): 450-454.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Penninger, J.M., Li, Y., Zhong, N. and Slutsky, A.S. (2020). Angiotensinconverting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine. 46(4): 586-590.
   PubMed Web of Science ®Google Scholar
• Xu, J., Zhao, S., Teng, T., Abdalla, A. E., Zhu, W., Xie, L., Wang, Y. and Guo, X. (2020). Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 12(2): 244.
   PubMed Web of Science ®Google Scholar
• Wan, Y., Shang, J., Graham, R., Baric, R.S. and Li, F. (2020). Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology. 94(7): e00127-00120.
   PubMed Web of Science ®Google Scholar
• Zhou, L., Niu, Z., Jiang, X., Zhang, Z., Zheng, Y., Wang, Z., Zhu, Y., Gao, L., Wang, X. and Sun, Q. (2020). Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and Furin proteases. In preprint. doi:https://doi.org/10.1101/2020.04.06.028522
   Google Scholar
• Jia, H. P., Look, D. C., Shi, L., Hickey, M., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S. and McCray, P.B. Jr. (2005). ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of Virology. 79(23): 14614-14621.
   PubMed Web of Science ®Google Scholar
• Prasanna, P.L. and Abilash, V. (2020). Coronaviruses pathogenesis, comorbidities and multiorgan damage-A review. Life Sciences. 255: 117839.
   PubMed Web of Science ®Google Scholar
• Huang, F., Guo, J., Zou, Z., Liu, J., Cao, B., Zhang, S., Li, H., Wang, W., Sheng, M., Liu, S., Pan, J., Bao, C., Zeng, M., Xiao, H., Qian, G., Hu, X., Chen, Y., Chen, Y., Zhao, Y., Liu, Q., Zhou, H., Zhu, J., Gao, H., Yang, S., Liu, X., Zheng, S., Yang, J., Diao, H., Cao, H., Wu, Y., Zhao, M., Tan, S., Guo, D., Zhao, X., Ye, Y., Wu, W., Xu, Y., Penninger, J.M., Li, D., Gao, G.F., Jiang, C. and Li, L. (2014). Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat. Commun. 5: 3595.
   PubMed Web of Science ®Google Scholar
• Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., Guo, F., Bai, T., Han, Z., Zhu, J., Zhou, H., Huang, F., Li, C., Lu, H., Li, N., Li, D., Jin, N., Penninger, J.M. and Jiang, C. (2014). Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat. Commun. 5: 3594.
   PubMed Web of Science ®Google Scholar
• Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., Bao, L., Zhang, B., Liu, G., Wang, Z., Chappell, M., Liu, Y., Zheng, D., Leibbrandt, A., Wada, T., Slutsky, A.S., Liu, D., Qin, C., Jiang, C. and Penninger, J.M. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine. 11(8): 875-879.
   PubMed Web of Science ®Google Scholar
• Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., Crackower, M.A., Fukamizu, A., Hui, C.C., Hein, L., Uhlig, S., Slutsky, A.S., Jiang, C. and Penninger, J.M. (2005). Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 436(7047): 112-116.
   PubMed Web of Science ®Google Scholar
• Patel, V. B., Bodiga, S., Basu, R., Das, S. K., Wang, W., Wang, Z., Lo, J., Grant, M.B., Zhong, J., Kassiri, Z. and Oudit, G.Y. (2012). Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis. Circ. Res. 110(10): 1322-35.
   PubMed Web of Science ®Google Scholar
• Ali, Q., Dhande, I., Samuel, P. and Hussain, T. (2016). Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin converting enzyme-2/angiotensin (1-7)/ Mas receptor and exhibit greater high-fat diet-induced kidney injury. Journal of the Renin-Angiotensin-Aldosterone System. 17(3): 1470320316661871.
   PubMed Web of Science ®Google Scholar
• Marshall, R.P. (2003). The pulmonary renin-angiotensin system. Current Pharmaceutical Design. 9(9): 715-722.
   PubMed Web of Science ®Google Scholar
• Marshall, R.P., Gohlke, P., Chambers, R.C., Howell, D.C., Bottoms, S.E., Unger, T., McAnulty, R.J. and Laurent, G.J. (2004). Angiotensin II and the fibroproliferative response to acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(1): L156-L164.
   PubMed Web of Science ®Google Scholar
• Szczepanska-Sadowska, E., Czarzasta, K. and Cudnoch-Jedrzejewska, A. (2018). Dysregulation of the renin-angiotensin system and the vasopressinergic system interactions in cardiovascular disorders. Current Hypertension Reports. 20(3): 19.
   PubMed Web of Science ®Google Scholar
• Carey, R.M. and Siragy, H.M. (2003). Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocrine Reviews, 24(3): 261-271.
   PubMed Web of Science ®Google Scholar
• Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J. and Wen, C. (2020). Cytokine storm in COVID-19: the current evidence and treatment strategies. Frontiers in Immunology. 11: 1708.
   PubMed Web of Science ®Google Scholar
• El Chami, H. and Hassoun, P.M. (2012). Immune and inflammatory mechanisms in pulmonary arterial hypertension. Progress in Cardiovascular Diseases. 55(2): 218-228.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Gao, Y., Qiao, L., Wang, W. and Chen, D. (2020). Inflammatory response cells during acute respiratory distress syndrome in patients with coronavirus disease 2019 (COVID-19). Annals of Internal Medicine. L20-0227.
   Google Scholar
• e Silva, A.C.S., Ferreira, R.N. and Miranda, A.S. (2017). The Renin Angiotensin System and Diabetes. In Mechanisms of Vascular Defects in Diabetes Mellitus. Springer. 275-291 pp.
   Google Scholar
• Chawla, T., Sharma, D. and Singh, A. (2010). Role of the renin angiotensin system in diabetic nephropathy. World Journal of Diabetes. 1(5): 141-145.
   PubMedGoogle Scholar
• Alghamri, M.S., Weir, N.M., Anstadt, M.P., Elased, K.M., Gurley, S.B. and Morris, M. (2013). Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice. Journal of Cardiovascular Pharmacology and Therapeutics. 18(2): 138-151.
   PubMed Web of Science ®Google Scholar
• Maddaloni, E. and Buzzetti, R. (2020). Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes/Metabolism Research Reviews. e33213321.
   Google Scholar
• Tipnis, S.R., Hooper, N.M., Hyde, R., Karran, E., Christie, G. and Turner, A.J. (2000). A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry. 275(43): 33238-33243.
   PubMed Web of Science ®Google Scholar
• Lau, T., Carlsson, P.O. and Leung, P. (2004). Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia. 47(2): 240-248.
   PubMed Web of Science ®Google Scholar
• Ghiani, B.U. and Masini, M. (1995). Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comparative Biochemistry and Physiology Part A: Physiology. 111(3): 439-444.
   PubMed Web of Science ®Google Scholar
• Carlsson, P.O. (2001). The renin-angiotensin system in the endocrine pancreas. Journal of the Pancreas. 2(1): 26-32.
   PubMedGoogle Scholar
• Hsueh, W. A. and Wyne, K. (2011). Renin-angiotensin-aldosterone system in diabetes and hypertension. The Journal of Clinical Hypertension. 13(4): 224-237.
   PubMed Web of Science ®Google Scholar
• Burns, K.D. (2000). Angiotensin II and its receptors in the diabetic kidney. American Journal of Kidney Diseases. 36(3): 449-467.
   PubMed Web of Science ®Google Scholar
• Bernardi, S., Michelli, A., Zuolo, G., Candido, R. and Fabris, B. (2016). Update on RAAS modulation for the treatment of diabetic cardiovascular disease. Journal of Diabetes Research. 2016: 8917578.
   PubMed Web of Science ®Google Scholar
• Navar, L.G. (2004). The intrarenal renin-angiotensin system in hypertension. Kidney International. 65(4): 1522-1532.
   PubMed Web of Science ®Google Scholar
• Van Buren, P.N. and Toto, R. (2011). Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Advances in Chronic Kidney Disease. 18(1): 28-41.
   PubMed Web of Science ®Google Scholar
• WHO. (2021a). The effects of virus variants on COVID-19 vaccines. Retrieved from https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-covid-19-vaccines
   Google Scholar
• Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M.K., Grant, M. and Oudit, G.Y. (2020). Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circulation Research. 126(10): 1456-1474.
   PubMed Web of Science ®Google Scholar
• Trifirò, G., Crisafulli, S., Andò, G., Racagni, G., Drago, F. and Pharmacology, I.S.O. (2020). Should patients receiving ACE inhibitors or angiotensin receptor blockers be switched to other antihypertensive drugs to prevent or improve prognosis of novel coronavirus disease 2019 (COVID-19)? Drug Safety. 43(6): 507-509.
   PubMed Web of Science ®Google Scholar
• Williams, B. and Zhang, Y. (2020). Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19. The Lancet Respiratory Medicine. 395(10238): 1671-1673.
   Google Scholar
• Sommerstein, R., Kochen, M.M., Messerli, F.H. and Gräni, C. (2020). Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Journal of the American Heart Association. 9(7): e016509.
   PubMed Web of Science ®Google Scholar
• Akhtar, S., Benter, I.F., Danjuma, M.I., Doi, S.A., Hasan, S.S. and Habib, A.M. (2020). Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety. Journal of Drug Targeting. 28(7-8): 683-699.
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar, F., Lavie, C.J., Perez-Quilis, C., Henry, B.M. and Lippi, G. (2020). Angiotensin-Converting Enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in Coronavirus Disease 2019. Mayo Clinic Proceedings. 95(6): 1222-1230.
   PubMed Web of Science ®Google Scholar
• Kuster, G. M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., Widmer, A.F. and Osswald, S. (2020). SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? European Heart Journal. 41(19): 1801-1803.
   PubMed Web of Science ®Google Scholar
• Ferrario, C.M. (2016). Cardiac remodelling and RAS inhibition. Therapeutic Advances in Cardiovascular Disease. 10(3): 162-171.
   PubMedGoogle Scholar
• Scheen, A. (2004). Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes & Metabolism. 30(6): 487-496.
   PubMed Web of Science ®Google Scholar
• Shiuchi, T., Cui, T.X., Wu, L., Nakagami, H., Takeda-Matsubara, Y., Iwai, M. and Horiuchi, M. (2002). ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension. 40(3): 329-334.
   PubMed Web of Science ®Google Scholar
• Goossens, G., Blaak, E., Schiffers, P., Saris, W. and Van Baak, M. (2006). Effect of shortterm ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects. Diabetologia. 49(12): 3009-3016.
   PubMed Web of Science ®Google Scholar
• Ruggenenti, P., Cravedi, P. and Remuzzi, G. (2010). The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nature Reviews Nephrology. 6(6): 319.
   PubMed Web of Science ®Google Scholar
• Ong, H.T., Ong, L.M. and Ho, J.J. (2013). Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in patients at high risk of cardiovascular events: a meta-analysis of 10 randomised placebo-controlled trials. ISRN Cardiology. 2013: 478597.
   PubMedGoogle Scholar
• Ko, D., Azizi, P., Koh, M., Chong, A., Austin, P., Stukel, T. and Jackevicius, C. (2019). Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction. Open Heart. 6(1): e001010.
   PubMed Web of Science ®Google Scholar
• Xu, R., Sun, S., Huo, Y., Yun, L., Huang, S., Li, G. and Yan, S. (2015). Effects of ACEIs versus ARBs on proteinuria or albuminuria in primary hypertension: a meta-analysis of randomized trials. Medicine. 94(39): e1560.
   PubMed Web of Science ®Google Scholar
• Ocaranza, M. P., Lavandero, S., Jalil, J. E., Moya, J., Pinto, M., Novoa, U., Apablaza, F., Gonzalez, L., Hernandez, C., Varas, M., Lopez, R., Godoy, I., Verdejo, H. and Chiong, M. (2010). Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro. J. Hypertens. 28(5): 1054-64.
   PubMed Web of Science ®Google Scholar
• Shu, G., Huang, J., Bao, C., Meng, J., Chen, H. and Cao, J. (2018). Effect of different proteases on the degree of hydrolysis and angiotensin I-converting enzyme-inhibitory activity in goat and cow milk. Biomolecules. 8(4): 101.
   Web of Science ®Google Scholar
• Goyal, A., Cusick, A.S. and Thielemier, B. (2017). ACE Inhibitors. In StatPearls: StatPearls Publisher.
   Google Scholar
• Khan, H., Nabavi, S.M. and Habtemariam, S. (2018). Anti-diabetic potential of peptides: Future prospects as therapeutic agents. Life Sciences. 193: 153-158.
   PubMed Web of Science ®Google Scholar
• Patil, P., Mandal, S., Tomar, S.K. and Anand, S. (2015). Food protein-derived bioactive peptides in management of type 2 diabetes. European Journal of Nutrition. 54(6): 863-880.
   PubMed Web of Science ®Google Scholar
• Betônico, C.C., Titan, S.M., Correa-Giannella, M.L.C., Nery, M. and Queiroz, M. (2016). Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control. Clinics. 71(1): 47-53.
   PubMed Web of Science ®Google Scholar
• FDA, U. (2016). FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm459579.htm.
   Google Scholar
• WHO. (2020b). WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients. Retrieved from https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients
   Google Scholar
• Zha, L., Li, S., Pan, L., Tefsen, B., Li, Y., French, N., Chen, L., Yang, G. and Villanueva, E.V. (2020). Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Medical Journal of Australia. 212(9): 416-420.
   PubMed Web of Science ®Google Scholar
• Wijesekara, I. and Kim, S.K. (2010). Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: Prospects in the pharmaceutical industry. Marine Drugs. 8(4): 1080-1093.
   PubMed Web of Science ®Google Scholar
• Admassu, H., Zhao, W., Yang, R., Gasmalla, M. and Alsir, E. (2015). Development of functional foods: seaweeds (algae) untouched potential and alternative resource-a review. International Journal of Scientific & Technology. 4(9): 108-115.
   Google Scholar
• Korhonen, H. and Pihlanto, A. (2006). Bioactive peptides: production and functionality. International Dairy Journal. 16(9): 945-960.
   Web of Science ®Google Scholar
• Udenigwe, C.C. and Aluko, R.E. (2012). Food protein-derived bioactive peptides: production, processing, and potential health benefits. Journal of Food Science. 77(1): R11-R24.
   PubMed Web of Science ®Google Scholar
• Chatterjee, C., Gleddie, S. and Xiao, C.W. (2018). Soybean bioactive peptides and their functional properties. Nutrients. 10(9): 1211.
   PubMed Web of Science ®Google Scholar
• Bhat, Z., Kumar, S. and Bhat, H.F. (2015). Bioactive peptides of animal origin: a review. Journal of Food Science and Technology. 52(9): 5377-5392.
   PubMed Web of Science ®Google Scholar
• Haug, A., Høstmark, A.T. and Harstad, O.M. (2007). Bovine milk in human nutrition-a review. Lipids in Health Disease. 6(1): 25.
   PubMedGoogle Scholar
• Yousr, M. and Howell, N. (2015). Antioxidant and ACE inhibitory bioactive peptides purified from egg yolk proteins. International Journal of Molecular Sciences. 16(12): 29161-29178.
   PubMed Web of Science ®Google Scholar
• Sanjukta, S. and Rai, A.K. (2016). Production of bioactive peptides during soybean fermentation and their potential health benefits. Trends in Food Science & Technology. 50: 1-10.
   Web of Science ®Google Scholar
• Aluko, R.E. (2015). Structure and function of plant protein-derived antihypertensive peptides. Current Opinion in Food Science. 4: 44-50.
   Web of Science ®Google Scholar
• Lee, S.Y. and Hur, S.J. (2019). Purification of novel angiotensin converting enzyme inhibitory peptides from beef myofibrillar proteins and analysis of their effect in spontaneously hypertensive rat model. Biomedicine & Pharmacotherapy. 116: 109046.
   PubMed Web of Science ®Google Scholar
• Frenhani, P.B. and Burini, R.C. (1999). Mechanisms of amino acids and oligopeptides absorption in humans. Arquivos de Gastroenterologia. 36(4): 227-237.
   PubMedGoogle Scholar
• Acquah, C., Di Stefano, E. and Udenigwe, C.C. (2018). Role of hydrophobicity in food peptide functionality and bioactivity. Journal of Food Bioactives. 4: 88-98.
   Google Scholar
• Silvestre, M.P.C., Silva, M.R., Silva, V.D.M., Souza, M.W.S.de., Lopes Junior, C.de.O. and Afonso, W.de.O. (2012). Analysis of whey protein hydrolysates: peptide profile and ACE inhibitory activity. Brazilian Journal of Pharmaceutical Sciences. 48(4): 747-757.
   Web of Science ®Google Scholar
• Lammi, C., Aiello, G., Boschin, G. and Arnoldi, A. (2019). Multifunctional peptides for the prevention of cardiovascular disease: A new concept in the area of bioactive food-derived peptides. Journal of Functional Foods. 55: 135-145.
   Web of Science ®Google Scholar
• Wu, Q., Jia, J., Yan, H., Du, J. and Gui, Z. (2015). A novel angiotensin-І converting enzyme (ACE) inhibitory peptide from gastrointestinal protease hydrolysate of silkworm pupa (Bombyx mori) protein: biochemical characterization and molecular docking study. Peptides. 68: 17-24.
   PubMed Web of Science ®Google Scholar
• Pina, A. and Roque, A. (2009). Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. Journal of Molecular Recognition. 22(2): 162-168.
   PubMed Web of Science ®Google Scholar
• Ma, F.F., Wang, H., Wei, C.K., Thakur, K., Wei, Z.J. and Jiang, L. (2019). Three novel ACE inhibitory peptides isolated from Ginkgo biloba seeds: Purification, inhibitory kinetic and mechanism. Frontiers in Pharmacology. 9: 1579.
   PubMed Web of Science ®Google Scholar
• Yu, Z., Guo, H., Shiuan, D., Xia, C., Zhao, W., Ding, L., Zheng, F. and Liu, J. (2020). Interaction mechanism of egg white-derived ACE inhibitory peptide TNGIIR with ACE and its effect on the expression of ACE and AT1 receptor. Food Science and Human Wellness. 9(1): 52-57.
   Google Scholar
• Wang, R., Lu, X., Sun, Q., Gao, J., Ma, L. and Huang, J. (2020). Novel ACE Inhibitory Peptides Derived from Simulated Gastrointestinal Digestion in Vitro of Sesame (Sesamum indicum L.) Protein and Molecular Docking Study. International Journal of Molecular Sciences. 21(3): 1059.
   Web of Science ®Google Scholar
• Ocaranza, M.P. and Jalil, J.E. (2012). Protective role of the ACE2/Ang-(1-9) axis in cardiovascular remodeling. International Journal of Hypertension. 2012: 594361.
   PubMedGoogle Scholar
• Lee, S.H., Qian, Z.J. and Kim, S.K. (2010). A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chemistry. 118(1): 96-102.
   Web of Science ®Google Scholar
• Fernández-Musoles, R., Castello-Ruiz, M., Arce, C., Manzanares, P., Ivorra, M.D. and Salom, J.B. (2014). Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect. Journal of Agricultural and Food Chemistry. 62(1): 173-181.
   PubMed Web of Science ®Google Scholar
• Wu, J., Liao, W. and Udenigwe, C.C. (2017). Revisiting the mechanisms of ACE inhibitory peptides from food proteins. Trends in Food Science Technology. 69: 214-219.
   Web of Science ®Google Scholar
• Hirota, T., Nonaka, A., Matsushita, A., Uchida, N., Ohki, K., Asakura, M. and Kitakaze, M. (2011). Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings. Heart Vessels, 26(5): 549-556.
   PubMed Web of Science ®Google Scholar
• Ibrahim, H.R., Ahmed, A.S. and Miyata, T. (2017). Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk. Journal of Advanced Research. 8(1): 63-71.
   PubMed Web of Science ®Google Scholar
• Memarpoor-Yazdi, M., Asoodeh, A. and Chamani, J. (2012). Structure and ACE-inhibitory activity of peptides derived from hen egg white lysozyme. International Journal of Peptide Research and Therapeutics. 18(4): 353-360.
   Web of Science ®Google Scholar
• Matsui, T., Li, C.H. and Osajima, Y. (1999). Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. Journal of Peptide Science. 5(7): 289-297.
   PubMed Web of Science ®Google Scholar
• Suh, H.J., Whang, J. and Lee, H. (1999). A peptide from corn gluten hydrolysate that is inhibitory toward angiotensin I converting enzyme. Biotechnology Letters. 21(12): 1055-1058.
   Web of Science ®Google Scholar
• Li, G.H., Le, G.W., Liu, H. and Shi, Y.H. (2005). Mung-bean protein hydrolysates obtained with alcalase exhibit angiotensin I-converting enzyme inhibitory activity. Food Science and Technology International. 11(4): 281-287.
   Web of Science ®Google Scholar
• Alu'datt, M.H., Ereifej, K., Abu-Zaiton, A., Alrababah, M., Almajwal, A., Rababah, T. and Yang, W. (2012). Anti-oxidant, anti-diabetic, and anti-hypertensive effects of extracted phenolics and hydrolyzed peptides from barley protein fractions. International Journal of Food Properties. 15(4): 781-795.
   Web of Science ®Google Scholar
• Kasina, S.V.S.K. and Baradhi, K.M. (2019). Dipeptidyl Peptidase IV (DPP IV) Inhibitors. In StatPearls: StatPearls Publishing.
   Google Scholar
• Tundis, R., Loizzo, M. and Menichini, F. (2010). Natural products as α-amylase and α-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Reviews in Medicinal Chemistry. 10(4): 315-331.
   PubMed Web of Science ®Google Scholar
• Lacroix, I.M. and Li-Chan, E.C. (2013). Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsin-treated whey proteins. Journal of Agricultural Food Chemistry. 61(31): 7500-7506.
   PubMed Web of Science ®Google Scholar
• Konrad, B., Anna, D., Marek, S., Marta, P., Aleksandra, Z. and Józefa, C. (2014). The evaluation of dipeptidyl peptidase (DPP)-IV, α-glucosidase and angiotensin converting enzyme (ACE) inhibitory activities of whey proteins hydrolyzed with serine protease isolated from Asian pumpkin (Cucurbita ficifolia). International Journal of Peptide Research and Therapeutics. 20(4): 483-491.
   PubMed Web of Science ®Google Scholar
• Amerongen, A.V., Beelen, M.J.C.B., Wolbers, L.A.M.Z., Gilst, W.H.V., Buikema, J.H. and Nelissen, J.W.P.M. (2009). World Intellectual Property Organization. Patent No. WO 2009128713
   Google Scholar
• Yu, Z., Yin, Y., Zhao, W., Yu, Y., Liu, B., Liu, J. and Chen, F. (2011). Novel peptides derived from egg white protein inhibiting alpha-glucosidase. Food Chemistry. 129(4): 1376-1382.
   Web of Science ®Google Scholar
• Yu, Z., Yin, Y., Zhao, W., Liu, J. and Chen, F. (2012). Anti-diabetic activity peptides from albumin against α-glucosidase and α-amylase. Food Chemistry. 135(3): 2078-2085.
   PubMed Web of Science ®Google Scholar
• Power, O., Nongonierma, A.B., Jakeman, P. and FitzGerald, R.J. (2014). Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes. Proceedings of the Nutrition Society. 73(1): 34-46.
   PubMed Web of Science ®Google Scholar
• Mojica, L. and De Mejía, E.G. (2016). Optimization of enzymatic production of anti-diabetic peptides from black bean (Phaseolus vulgaris L.) proteins, their characterization and biological potential. Food Function. 7(2): 713-727.
   Google Scholar
• González-Montoya, M., Hernández-Ledesma, B., Mora-Escobedo, R. and Martínez-Villaluenga, C. (2018). Bioactive peptides from germinated soybean with anti-diabetic potential by inhibition of dipeptidyl peptidase-IV, α-amylase, and α-glucosidase enzymes. International Journal of Molecular Sciences. 19(10): 2883.
   Web of Science ®Google Scholar
• Gaudel, C., Nongonierma, A.B., Maher, S., Flynn, S., Krause, M., Murray, B.A., Kelly, P.M., Baird, A.W., FitzGerald, R.J. and Newsholme, P. (2013). A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice. The Journal of Nutrition. 143(7): 1109-1114.
   PubMed Web of Science ®Google Scholar
• Barnes, M.J., Uruakpa, F. and Udenigwe, C. (2015). Influence of cowpea (Vigna unguiculata) peptides on insulin resistance. Journal of Nutritional Health & Food Science. 3(2): 1-3.
   Google Scholar
• Zhang, H., Wang, J., Liu, Y. and Sun, B. (2015). Peptides Derived from Oats Improve Insulin Sensitivity and Lower Blood Glucose in Streptozotocin-Induced Diabetic Mice. Journal of Biomedical Science. 4(1).
   Google Scholar
• Huang, F.J. and Wu, W.T. (2010). Purification and characterization of a new peptide (s-8300) from shark liver. Journal of Food Biochemistry. 34(5): 962-970.
   Web of Science ®Google Scholar
• Lavigne, C., Tremblay, F., Asselin, G., Jacques, H. and Marette, A. (2001). Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. American Journal of Physiology-Endocrinology Metabolism. 281(1): E62-E71.
   PubMed Web of Science ®Google Scholar
• Son, M., Chan, C. B. and Wu, J. (2018). Egg white ovotransferrin-derived ACE inhibitory peptide ameliorates angiotensin II-stimulated insulin resistance in skeletal muscle cells. Molecular Nutrition & Food Research. 62(4): 1700602.
   Web of Science ®Google Scholar
• Matsui, T., Oki, T. and Osajima, Y. (1999). Isolation and identification of peptidic α-glucosidase inhibitors derived from sardine muscle hydrolyzate. Zeitschrift für Naturforschung C. 54(3-4): 259-263.
   PubMedGoogle Scholar
• Liu, M., Gao, Y., Zhang, Y., Shi, S., Chen, Y. and Tian, J. (2020). The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis. The Journal of Infection. 81(3): e93-e95.
   Web of Science ®Google Scholar
• Zhao, Y., Nie, H.X., Hu, K., Wu, X.J., Zhang, Y.T., Wang, M.M., Wang, T., Zheng, Z.S., Li, X.C. and Zeng, S.L. (2020). Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infectious Diseases of Poverty. 9(1): 1-10.
   PubMed Web of Science ®Google Scholar
• Hannan, M.A., Rahman, M.A., Rahman, M.S., Sohag, A.A.M., Dash, R., Hossain, K.S., Farjana, M. and Uddin, M.J. (2020). Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response. Immunology Letters. 226: 38-45.
   PubMed Web of Science ®Google Scholar
• Hannan, M., Islam, M. and Uddin, M. (2020). Self-confidence as an immune-modifying psychotherapeutic intervention for COVID-19 patients and understanding of its connection to CNS-endocrine-immune axis. Journal of Advanced Biotechnology and Experimental Therapeutics. 3(4): 14.
   Google Scholar
• Chalamaiah, M., Yu, W. and Wu, J. (2018). Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: A review. Food Chemistry. 245: 205-222.
   PubMed Web of Science ®Google Scholar
• Kang, H.K., Lee, H.H., Seo, C.H. and Park, Y. (2019). Antimicrobial and immunomodulatory properties and applications of marine-derived proteins and peptides. Marine Drugs. 17(6): 350.
   PubMed Web of Science ®Google Scholar
• Egusa, S. and Otani, H. (2009). Characterization of a cellular immunostimulating peptide from a soybean protein fraction digested with peptidase R. Journal of Nutritional Science and Vitaminology. 55(5): 428-433.
   PubMed Web of Science ®Google Scholar
• Yuda, N., Tanaka, M., Tokushima, M. and Abe, F. (2021). Safety evaluation of high-dose intake of casein-derived peptide Met-Lys-Pro in healthy adults: A randomized, double-blind, placebo-controlled trial. Food Science & Nutrition. 9(2): 662-671.
   PubMed Web of Science ®Google Scholar
• Devasia, S., Kumar, S., Stephena, P., Inoue, N., Sugihara, F. and Koizumi, S. (2019). A Double Blind, Randomised, Four Arm Clinical Study to Evaluate the Safety, Efficacy and Tolerability of Collagen Peptide as a Nutraceutical Therapy in the Management of Type II Diabetes Mellitus. Journal of Diabetes & Metabolism. 11(1): 839.
   Google Scholar
• Samsamikor, M., Mackay, D., Mollard, R.C. and Aluko, R.E. (2020). A double-blind, randomized, crossover trial protocol of whole hemp seed protein and hemp seed protein hydrolysate consumption for hypertension. Trials. 21(1): 354.
   PubMed Web of Science ®Google Scholar
• Fuller, N. R., Caterson, I. D., Sainsbury, A., Denyer, G., Fong, M., Gerofi, J., Baqleh, K., Williams, K.H., Lau, N.S. and Markovic, T.P. (2015). The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. Am. J. Clin. Nutr. 101(4): 705-713.
   PubMed Web of Science ®Google Scholar
• Korhonen, H. (2009). Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods. 1(2): 177-187.
   Web of Science ®Google Scholar
• McClements, D.J., Zou, L., Zhang, R., Salvia-Trujillo, L., Kumosani, T. and Xiao, H. (2015). Enhancing nutraceutical performance using excipient foods: designing food structures and compositions to increase bioavailability. Comprehensive Reviews in Food Science and Food Safety. 14(6): 824-847.
   Web of Science ®Google Scholar
• Ding, L., Wang, L., Yu, Z., Zhang, T. and Liu, J. (2016). Digestion and absorption of an egg white ACE-inhibitory peptide in human intestinal Caco-2 cell monolayers. International Journal of Food Sciences and Nutrition. 67(2): 111-116.
   PubMed Web of Science ®Google Scholar
• Yamada, Y., Matoba, N., Usui, H., Onishi, K. and Yoshikawa, M. (2002). Design of a highly potent anti-hypertensive peptide based on ovokinin (2-7). Bioscience, Biotechnology, and Biochemistry. 66(6): 1213-1217.
   PubMed Web of Science ®Google Scholar
• Chen, T.L., Lo, Y.C., Hu, W.T., Wu, M.C., Chen, S.T. and Chang, H.M. (2003). Microencapsulation and modification of synthetic peptides of food proteins reduces the blood pressure of spontaneously hypertensive rats. Journal of Agricultural Food Chemistry. 51(6): 1671-1675.
   PubMed Web of Science ®Google Scholar
• Jao, C.L., Huang, S.L. and Hsu, K.C. (2012). Angiotensin I-converting enzyme inhibitory peptides: Inhibition mode, bioavailability, and antihypertensive effects. BioMedicine. 2(4): 130-136.
   Google Scholar
• Vermeirssen, V., Van Camp, J. and Verstraete, W. (2004). Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition. 92(3): 357-366.
   PubMed Web of Science ®Google Scholar
• Sharma, R. (2012). Enzyme inhibition: mechanisms and scope. In Enzyme inhibition and bioapplications. IntechOpen. 3-36 pp.
   Google Scholar
• Li, Y., Zeng, Z., Li, Y., Huang, W., Zhou, M., Zhang, X. and Jiang, W. (2015). Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock. 43(4): 395-404.
   PubMed Web of Science ®Google Scholar
• Ferrario, C.M., Jessup, J., Chappell, M.C., Averill, D.B., Brosnihan, K.B., Tallant, E.A., Diz, D.I. and Gallagher, P.E. (2005). Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 111(20): 2605-2610.
   PubMed Web of Science ®Google Scholar
• Lopez, E.O., Parmar, M., Pendela, V.S. and Terrell, J.M. (2020). Lisinopril. In StatPearls: StatPearls Publishing.
   Google Scholar
• Faruqi, A. and Jain, A. (2020). Enalapril. In StatPearls: StatPearls Publishing.
   Google Scholar
• Danilogorskaya, Y.A., Zheleznykh, E.A., Privalova, E.A., Belenkov, Y.N., Shchendrigina, A.A., Kozhevnikova, M.V., Shakaryants, G.A., Zektser, V.Y., Lishuta, A.S. and Khabarova, N.V. (2020). Vasoprotective Effects of Prolonged Therapy With Perindopril A in Patients with Hypertension Including Concomitant Type 2 Diabetes Mellitus. Kardiologiia. 60(1): 4-9.
   PubMed Web of Science ®Google Scholar
• Hodzic, E., Pecar, E., Dzubur, A., Smajic, E., Hondo, Z., Delic, D. and Rustempasic, E. (2020). Efficacy and Safety of Perindopril in Patients with Essential Hypertension. Materia Socio-Medica. 32(1): 4.
   PubMedGoogle Scholar
• Tandan, N. and Cassagnol, M. (2020). Quinapril. In StatPearls: StatPearls Publishing.
   Google Scholar
• Deshotels, M.R., Xia, H., Sriramula, S., Lazartigues, E. and Filipeanu, C.M. (2014). Angiotensin-II mediates ACE2 Internalization and Degradation through an Angiotensin-II type I receptor-dependent mechanism. Hypertension. 64(6): 1368-1375.
   PubMed Web of Science ®Google Scholar
• Kramkowski, K., Mogielnicki, A., Leszczynska, A. and Buczko, W. (2010).Angiotensin-(1-9): the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats. Journal of Physiology and Pharmacology. 61(3): 317.
   PubMed Web of Science ®Google Scholar
• Furuhashi, M., Moniwa, N., Mita, T., Fuseya, T., Ishimura, S., Ohno, K., Shibata, S., Tanaka, M., Watanabe, Y., Akasaka, H., Ohnishi, H., Yoshida, H., Takizawa, H., Saitoh, S., Ura, N., Shimamoto, K. and Miura, T. (2015). Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Am. J. Hypertens. 28(1): 15-21.
   PubMed Web of Science ®Google Scholar
• Haller, H., Ito, S., Izzo, J.L. Jr., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T.J., Ritz, E., Ruilope, L.M., Rump, L.C. and Viberti, G. (2011). Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N. Engl. J. Med. 364(10): 907-17.
   PubMed Web of Science ®Google Scholar
• Yoganand, P.S., Chacko, R., Mishra, R.K.C., Kumar, R.P. and Kundu, S. (2020). Multifacted Tesmisartan: Candidate for New Therapeutic Approaches. Medico Research Chronicles. 7(1): 45-49.
   Google Scholar
• Croom, K.F., Curran, M.P., Goa, K.L. and Perry, C.M. (2004). Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs. 64(9): 999-1028.
   PubMed Web of Science ®Google Scholar
• Robles, N., Martín-Águeda, B., López-Muñoz, F., Alamo, C. and Study, I.o.t.E. (2005). Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients. International Journal of Clinical Practice. 59(4): 478-484.
   PubMed Web of Science ®Google Scholar
• Scheen, A. (2004). Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: part 2. Overview of physiological and biochemical mechanisms. Diabetes & Metabolism. 30(6): 498-505.
   PubMed Web of Science ®Google Scholar
• Suzuki, K., Nakagawa, O. and Aizawa, Y. (2008). Improved early-phase insulin response after candesartan treatment in hypertensive patients with impaired glucose tolerance. Clinical Experimental Hypertension. 30(5): 309-314.
   PubMed Web of Science ®Google Scholar
• Mohanty, D., Mohapatra, S., Misra, S. and Sahu, P. (2016). Milk derived bioactive peptides and their impact on human health-A review. Saudi Journal of Biological Sciences. 23(5): 577-583.
   PubMed Web of Science ®Google Scholar
• Fujita, H. and Yoshikawa, M. (1999). LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology. 44(1-2): 123-127.
   PubMed Web of Science ®Google Scholar
• Li Chan, E.C., Hunag, S.L., Jao, C.L., Ho, K.P. and Hsu, K.C. (2012). Peptides derived from Atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. Journal of Agricultural Food Chemistry. 60(4): 973-978.
   PubMed Web of Science ®Google Scholar
• Huang, D., Yang, L., Wang, C., Ma, S., Cui, L., Huang, S., Sheng, X., Weng, Q. and Xu, M. (2014). Immunostimulatory activity of protein hydrolysate from oviductus ranae on macrophage in vitro. Evidence-Based Complementary Alternative Medicine. 2014: 180234
   PubMed Web of Science ®Google Scholar
• Siow, H.L. and Gan, C.Y. (2016). Extraction, identification, and structure-activity relationship of antioxidative and α-amylase inhibitory peptides from cumin seeds (Cuminum cyminum). Journal of Functional Foods. 22: 1-12.
   Web of Science ®Google Scholar
• Lammi, C., Zanoni, C. and Arnoldi, A. (2015). IAVPGEVA, IAVPTGVA, and LPYP, three peptides from soy glycinin, modulate cholesterol metabolism in HepG2 cells through the activation of the LDLR-SREBP2 pathway. Journal of Functional Foods. 14: 469-478.
   Web of Science ®Google Scholar
• Ibrahim, H.R., Nanbu, F. and Miyata, T. (2021). Potent antioxidant peptides derived from honey major protein enhance tolerance of eukaryotic cells toward oxidative stress. Food Production, Processing and Nutrition. 3(1): 1-10.
   Google Scholar
• García-Mora, P., Martín-Martínez, M., Bonache, M.A., González-Múniz, R., Peñas, E., Frias, J. and Martinez-Villaluenga, C. (2017). Identification, functional gastrointestinal stability and molecular docking studies of lentil peptides with dual antioxidant and angiotensin I converting enzyme inhibitory activities. Food Chemistry. 221: 464-472.
   PubMed Web of Science ®Google Scholar